Glycos Biotechnologies, Inc. (GlycosBio), a pioneer in metabolic engineering, and Eureka Genomics, a leader in analysis of next generation genomic sequencing data, announced today the sequencing of the genome of a proprietary bacterium that will support the growth of the emerging biorefinery industry. The new bacterial strain plays an important role in GlycosBio